Chioma Umeha
Phamatex Industries Limited, one of the leading
manufacturers of pharmaceutical products in Nigeria has been named ‘Best
Pharmaceutical Company of the Year’ by the Health Writers Association of
Nigeria (HEWAN).
According to the leadership of the association who
organised the awards in collaboration with Maximpact Communications, the award
was conferred on Phamatex because of its good manufacturing practices, quality
products, availability and affordability of her products and investment in
state-of-the-art manufacturing plant and
technology. The company’s ant-malarial, Lumapil, was also named, “Best
Anti-malarial of the Year.”
Receiving the awards on behalf of staff and management
of Phamatex, Prince Christopher Nebe, Managing Director/Chief Executive Officer
said,“ On behalf of Phamatex Group which comprises of Phamatex Industries Ltd and Phamatex Nigeria Ltd, I express
great delight and humbled by these awards and recognition from HEWAN. Phamatex
is a group of companies that is into manufacturing and importation of drugs in
Nigeria. We have one of the finest ranges of products in the country which
includes Lumapil which incidentally won HEWAN’s Anti-malarial of the Year. We are also the exclusive agent of Hovid
products in Nigeria.
“We are known for high quality and these awards
are an encouragement to continue to maintain quality standards. We are WHO and
NAFDAC compliant. I thank HEWAN and commend them for these awards. We promise
that the standard will be maintained,’’
Speaking on behalf of HEWAN, Ms Chioma Obinna, who
is the president of the association, said, ‘’Phamatex has contributed a lot to
pharmaceutical manufacturing and distribution in Nigeria which should be
recognised. We used a set of rigorous criteria to arrive at the decision to
confer these prestigious awards on Phamatex and Lumapil.’’
The 2018 HEWAN awards and symposium had the theme:
‘’ Rewarding and Promoting Excellence in our Healthcare Delivery System.”
Experts at the event proffered solutions to the
challenges. It also served as an opportunity to recognise companies and
individuals who distinguished themselves through quality network service
delivery.
